Applications Published 24 October 2001
Published: 1-Jul-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
A method for treating patients with acne by administering a cyclic GMP PDE inhibitor
Cell Pathways 1146866*
Antibacterial hydroxamic acid derivatives
British Biotech Pharmaceuticals 1146867*
Anti-inflammatory agents
British Biotech Pharmaceuticals 1146868*
Inhibition of STAT3 signal transduction for human cancer therapy
University of South Florida 1146869*
Antidepressant heterocyclic compounds
Bristol-Myers Squibb 1146871*
Use of angiotensin II receptor antagonists for treating acute myocardial infarction
Novartis 1146872*
Anti-androgens and methods for treating disease
SmithKline Beecham 1146873*
Vitronectin receptor antagonist
SmithKline Beecham 1146874*
MYT1 kinase inhibitor
SmithKline Beecham 1146875*
Compsns having improved stability
Procter & Gamble 1146876*
Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
Allergan Sales 1146877*
Biochemical treatments used in human treatment
Cochran, Timothy 1146878*
Methods and compsns for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs
Rockefeller University 1146879*
Use of phosphororganic compounds for the prophylactic and therapeutic treatment of infections
Jomaa Pharmaka 1146880*
Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
Bullerdiek, Joem 1146881*
Combination of zidovudine (AZT) with nuceloside analogues for treatment of feline immunodeficiency virus
The University of Florida 1146882*
Modulation of immune response by Rabivirin
ICN Pharmaceuticals 1146883*
Novel polymer formulations containing perfluorinated compounds for the engineering of cells and tissues for transplantation that improves cell metabolism and survival, and method of making same
Biomm 1146884*
Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic compsn
Indena 1146886*
Glycopeptide antibiotics containing desmethylvancosamine residue, combinatorial libraries of same and methods of producing same
Princeton University 1146887*
Specific therapeutic interventions obtained by interference with redistribution and/or targeting
BioImage 1146888*
Identification of specific differentially expressed mycobacterial antigens
Chiron Behring 1146889*
Inhibiting development of microvessels within vascular walls
Medstar Research 1146891*
Baff, inhibitors thereof and their use in the modulation of B-cell response
BIOGEN 1146892*
Neurite derived growth factors for use in the treatment of muscular dystrophy
Khurana, Tejvir 1146893*
Use of Thank, a TNF analogue that activates apoptosis
Research Development Foundation 1146894*
Method for increasing circulating platelets for collection and cryopreservation using thrombopoietin compsns
Board of Regents, The University of Texas System 1146895*
Monodisperse hexameric a cylated insulin analogue formulations
Eli Lilly 1146896*
Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
Dony, Carola 1146897*
Vaccine-mediated treatment of neurological disorders
During, Matthew John 1146898*
Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorder
Regeneron Pharmaceuticals 1146899*
DNA vaccines against hantavirus infections
US Medical Research Institute of Infectious Diseases 1146900*
Potentiation of anti-CD38-immunotoxin cytotoxicity
Research Development Foundation 1146901*
Treatment of autoimmune diseases by an agonistic CD40-binding protein
Londei, Marco 1146902*
Glypicans for the detection and treatment of human carcinoma
The Regents of the University of California 1146903*
Use of hydroxyurea and a reverse transcriptase inhibitor to reduce autovaccination by autologous HIV
Lori, Franco; Lisziewica, Juliana 1146904*
COX-2 inhibitors in combination with NMDA-blockers for treating pain
Algos Pharmaceutical 1146905*
Mucosal delivery system
Alk-Abello 1146906*
Use of cationic lipids to geenrate anti-tumour immunity
Genzyme 1146907*
Formulations comprising antisense nucleotides to connexins
University College London 1146908*
Method of treating cancer by restoration of PP32 function
Johns Hopkins University 1146909*
